link to webcast
Category: Webcast
TG4001+Avelumab vs Avelumab Single-Agent Phase II Update
link to webcast
2024 Half-Year Results
link to webcast
New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio
link to webcast
Transgene R&D Day (Paris, France)
Lien
TG4050, First positive clinical data from Phase I clinical trials
link to webcast
Detailed results of the Phase 1b/2 trial of TG4001 and avelumab in advanced HPV-positive cancers presented at SITC 2020
Link to webcast